Literature DB >> 16858366

Epidemiology: testosterone and the metabolic syndrome.

J Svartberg1.   

Abstract

Low levels of testosterone, hypogonadism, have several common features with the metabolic syndrome. In the Tromsø Study, a population-based health survey, testosterone levels were inversely associated with anthropometrical measurements, and the lowest levels of total and free testosterone were found in men with the most pronounced central obesity. Total testosterone was inversely associated with systolic blood pressure, and men with hypertension had lower levels of both total and free testosterone. Furthermore, men with diabetes had lower testosterone levels compared to men without a history of diabetes, and an inverse association between testosterone levels and glycosylated hemoglobin was found. Thus, there are strong associations between low levels of testosterone and the different components of the metabolic syndrome. In addition, an independent association between low testosterone levels and the metabolic syndrome itself has recently been presented in both cross-sectional and prospective population-based studies. Thus, testosterone may have a protective role in the development of metabolic syndrome and subsequent diabetes mellitus and cardiovascular disease in aging men. However, clinical trials are needed to confirm this assumption.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16858366     DOI: 10.1038/sj.ijir.3901499

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  12 in total

1.  New therapy via targeting androgen receptor in monocytes/macrophages to battle atherosclerosis.

Authors:  Chiung-Kuei Huang; Haiyan Pang; Lin Wang; Yuanjie Niu; Jie Luo; Eugene Chang; Janet D Sparks; Soo Ok Lee; Chawnshang Chang
Journal:  Hypertension       Date:  2014-03-31       Impact factor: 10.190

2.  Effects of testosterone undecanoate replacement and withdrawal on cardio-metabolic, hormonal and body composition outcomes in severely obese hypogonadal men: a pilot study.

Authors:  D Francomano; R Bruzziches; G Barbaro; A Lenzi; A Aversa
Journal:  J Endocrinol Invest       Date:  2014-03-18       Impact factor: 4.256

3.  Waist-to-height ratio as a predictor of serum testosterone in ageing men with symptoms of androgen deficiency.

Authors:  Carolyn A Allan; Roger E Peverill; Boyd Jg Strauss; Elise A Forbes; Robert I McLachlan
Journal:  Asian J Androl       Date:  2011-04-11       Impact factor: 3.285

4.  Metabolic syndrome and erectile dysfunction among obese non-diabetic subjects.

Authors:  A Gatti; E Mandosi; M Fallarino; A Radicioni; E Morini; F Maiani; V Trischitta; A Lenzi; S Morano
Journal:  J Endocrinol Invest       Date:  2009-05-05       Impact factor: 4.256

5.  Biomarkers and Noncalcified Coronary Artery Plaque Progression in Older Men Treated With Testosterone.

Authors:  Kashif Shaikh; Susan S Ellenberg; Rine Nakanishi; Peter J Snyder; Juhwan Lee; Nanette K Wenger; Cora E Lewis; Ronald S Swerdloff; Peter Preston; Sajad Hamal; Alisa Stephens-Sheilds; Shalender Bhasin; Lavanya Cherukuri; Jane A Cauley; Jill P Crandall; Glenn R Cunningham; Kristine E Ensrud; Alvin M Matsumoto; Mark E Molich; Venkata M Alla; Divya Birudaraju; Negin Nezarat; Kelash Rai; Shone Almeida; Sion K Roy; Mohammad Sheikh; George Trad; Mathew J Budoff
Journal:  J Clin Endocrinol Metab       Date:  2020-07-01       Impact factor: 5.958

6.  A case series of the safety and efficacy of testosterone replacement therapy in renal failure and kidney transplant patients.

Authors:  Ahmad Majzoub; Daniel A Shoskes
Journal:  Transl Androl Urol       Date:  2016-12

7.  Improvement of the diabetic foot upon testosterone administration to hypogonadal men with peripheral arterial disease. Report of three cases.

Authors:  Svetlana Kalinchenko; Alexandr Zemlyanoy; Louis J Gooren
Journal:  Cardiovasc Diabetol       Date:  2009-03-28       Impact factor: 9.951

8.  Clinical and biochemical correlates of hypogonadism in men with type 2 diabetes mellitus.

Authors:  Ezekiel Musa; Jibril Mohammed El-Bashir; Fatima Sani-Bello; Adamu Girei Bakari
Journal:  Pan Afr Med J       Date:  2021-03-19

9.  The influence of obesity-related single nucleotide polymorphisms on BMI across the life course: the PAGE study.

Authors:  Mariaelisa Graff; Penny Gordon-Larsen; Unhee Lim; Jay H Fowke; Shelly-Ann Love; Megan Fesinmeyer; Lynne R Wilkens; Shawyntee Vertilus; Marilyn D Ritchie; Ross L Prentice; Jim Pankow; Kristine Monroe; JoAnn E Manson; Loïc Le Marchand; Lewis H Kuller; Laurence N Kolonel; Ching P Hong; Brian E Henderson; Jeff Haessler; Myron D Gross; Robert Goodloe; Nora Franceschini; Christopher S Carlson; Steven Buyske; Petra Bůžková; Lucia A Hindorff; Tara C Matise; Dana C Crawford; Christopher A Haiman; Ulrike Peters; Kari E North
Journal:  Diabetes       Date:  2013-01-08       Impact factor: 9.461

Review 10.  The triad of erectile dysfunction, hypogonadism and the metabolic syndrome.

Authors:  R Shabsigh; S Arver; K S Channer; I Eardley; A Fabbri; L Gooren; A Heufelder; H Jones; S Meryn; M Zitzmann
Journal:  Int J Clin Pract       Date:  2008-02-02       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.